Based on the observed PKCε downregulation in the ALS condition, we wondered about the downstream pharmacological effects of PKCε agonism in vitro and examined the biological outcomes of PKCε pulse activation by Bryostatin-1 in WT and G93A NSC-34 cells in two different paradigms of cell death models. This evidence concerns the gene PRKCE and amyotrophic lateral sclerosis.